Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients

ABSTRACTS: BACKGROUND: The aim of this sub-study is to explore the incidence of skin rash among advanced breast cancer(ABC) patients in a phase II trial treated with weekly nab-paclitaxel and cisplatin combination. METHODS: Nab-paclitaxel(125 mg/m(2)) was administered on days 1, 8, 15, followed by c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Li Chen, Wang, Bi Yun, Sun, Si, Zhang, Jian, Jia, Zhen, Lu, Yun Hua, Di, Geng Hong, Shao, Zhi Ming, Hu, Xi Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658926/
https://www.ncbi.nlm.nih.gov/pubmed/23659317
http://dx.doi.org/10.1186/1471-2407-13-232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658926/
https://www.ncbi.nlm.nih.gov/pubmed/23659317
http://dx.doi.org/10.1186/1471-2407-13-232

Ejemplares similares